Antimicrobial Agents and Chemotherapy · 2002 · 40 citations · 7 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsRespiratory InfectionsRespiratory Tract InfectionsAntibiotic Resistance In Respiratory PathogensAntibiotic Susceptibility TestingPneumococcal DiseaseQuinolone Resistance MechanismsSurveillance Studies
Six quinolones were tested on 817 consecutive pneumococcal isolates for which ciprofloxacin MICs were high (> or =2 microg/ml); the isolates had been collected during two recent Spanish surveillance studies. For strains for which the ciprofloxacin MIC was >or =4 microg/ml, the MICs at which 90% of the isolates tested against gemifloxacin, moxifloxacin, gatifloxacin, sparfloxacin, levofloxacin, and ofloxacin were inhibited were 0.25, 1, 1, 1, 4 and 16 microg/ml, respectively, and the corresponding prevalences of resistance were 0, 1, 4.5, 9.5, 8.4 and 23%. The proportion of isolates for which the ciprofloxacin MIC is high has increased over time.
7
Emilio Pérez‐Trallero, Carlos Fernández-Mazarrasa, César Garcı́a-Rey et al. · Antimicrobial Agents and Chemotherapy · 2001 · 209 citations
Fernando Baquero, José Ángel Garcı́a-Rodrı́guez, Juan García de Lomas et al. · Antimicrobial Agents and Chemotherapy · 1999 · 168 citations · Full text